| Date Filed | Type | Description |
| 10/05/2023 |
8-K
| Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arran... |
| 09/26/2023 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 08/15/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 07/27/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 05/26/2023 |
8-K
| Other Events Interactive Data |
| 05/23/2023 |
8-K
| Other Events Interactive Data |
| 05/22/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 05/15/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/08/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 05/01/2023 |
10-K/A
| Annual Report for the period ended December 31, 2022 [amend] |
| 04/14/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/31/2023 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 03/06/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 12/15/2022 |
8-K
| Quarterly results |
| 11/28/2022 |
8-K
| Quarterly results |
| 11/04/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/03/2022 |
8-K
| Quarterly results |
| 10/06/2022 |
8-K
| Quarterly results |
| 09/07/2022 |
DEFA14C
| Form DEFA14C - Additional information statement materials, definitive: |
| 08/24/2022 |
DEF 14C
| Form DEF 14C - Other definitive information statements: |
| 08/19/2022 |
8-K
| Quarterly results |
| 08/05/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 08/04/2022 |
8-K
| Quarterly results |
| 06/10/2022 |
8-K
| Quarterly results |
| 06/10/2022 |
4
| BLASZYK MICHAEL D (Director) has filed a Form 4 on NantHealth, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.5823, valued at
$58.2k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 05/05/2022 |
8-K
| Quarterly results |
| 04/27/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/27/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 02/25/2022 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 02/25/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 02/24/2022 |
8-K
| Quarterly results |
|